2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Diethylcarbamazine: new trials by email Literature Review of Diethylcarbamazine trials Research Report on Diethylcarbamazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Moxidectin for LF, Cote d'Ivoire (DOLF) Ivermectin, Diethylcarbamazine, Albendazole - Lymphatic Filariasis | Phase 3 | Completed | Washington University School of Medicine | 164 | 2020-08-20 | 2026-01-29 |
| Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws | Phase 3 | Completed | Lihir Medical Centre | 20000 | 2018-10-01 | 2019-02-28 |
Elephantiasis, Filarial (2) · Neglected Diseases (1) · Scabies (1) · Strongyloidiasis (1) · Trachoma (1) · Yaws (1)
Lihir Medical Centre (1) · Washington University School of Medicine (1)
Côte d’Ivoire (1) · Papua New Guinea (1)
Benjamin Koudou, PhD (1) · Catherine Bjerum, MD, MPH (1) · Lucy John, MD (1) · Philip Budge, MD, PhD (1) · Toki Pascal Gabo, MD (1)